Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Merck KGaA

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Merck KGaA's 2013 sales performance.

Merck KGaA

Novimmune expands senior management team

Novimmune expands senior management team Before joining Alvotech, Fleurant spent 10 years as region head quality assurance, Europe for Novartis and implemented global quality systems at Merck Serono.

Novartis seeks first-line use for lung cancer drug Zykadia

Novartis seeks first-line use for lung cancer drug Zykadia Looks to go head-to-head with Pfizer/Merck KGaA’s Xalkori and Roche’s Alecensa. ... Merck KGaA's ALK blocker Xalkori (crizotinib), with EU conditional approval coming through last year.

EMD Serono appoints neurology and immunology SVP

EMD Serono appoints neurology and immunology SVP Promotes head of US Fertility and Endocrinology Craig Millian. EMD Serono, the US-based biopharma business of Germany's Merck KGaA, has promoted Craig Millian to senior vice president of neurology ... Gary Zieziula, president and managing director of EMD

Deal Watch August 2016

Deal Watch August 2016 Merck KGaA. Schering AG. $17bn. Schering AG sold to Bayer for $20bn.

EMD Serono president James Hoyes joins consultants RxC

EMD Serono president James Hoyes joins consultants RxC He was previously president of EMD Serono - as the US biopharma operations of Germany's Merck are known - having initially joined the company in 2004 as VP of neurology marketing. ... Prior to joining EMD Serono, Hoyes held leadership positions with the

[ Previous 5 results ] 24 25 26 27 28 29 30 31 32 33 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

Personalised medicine: driving a need for greater diversity in clinical trials
Kate Shaw, Innovative Trials' Founder & CEO, investigates one of the biggest challenges facing clinical research today....
Congresses and conferences
Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay...
Cervical Cancer Prevention Month
In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...